Monteris Medical
Monteris Medical is a private medical device company that develops the NeuroBlate System, a robotic MR-guided LITT platform for minimally invasive brain surgery. It sells capital equipment and consumables to hospitals and neurosurgeons treating brain tumors, radiation necrosis, and drug-resistant epilepsy across North America.
- Company typePrivate
- Founded1999
- HeadquartersMinnetonka, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Monteris Medical does
Monteris Medical is a privately held medical device company founded in 1999 that develops and commercializes the NeuroBlate System, the only robotic MR-guided laser interstitial thermal therapy (LITT) platform designed specifically for use in the brain. Headquartered in Minnetonka, Minnesota with a Canadian office in Winnipeg, Manitoba, the company targets neurosurgeons and hospitals/health systems for the minimally invasive treatment of brain tumors, radiation necrosis, and drug-resistant epilepsy. The platform addresses the need for alternatives to open craniotomy, particularly for deep-seated lesions, recurrent tumors, fragile patients, and drug-resistant epilepsy patients who have failed more than two medication regimens.
The NeuroBlate System is an integrated platform comprising capital equipment (robotic MR-guided ablation workstation), consumable laser probes (FullFire, SideFire, and the NB3 1.6mm — the smallest commercially available brain laser probe), Fusion-S 3D visualization and control software, the AtamA patient board, and the MiniBolt cranial bolt system. The system uses proprietary cooled laser probe technology that enables ablation of lesions 3 cm or larger in diameter while preserving surrounding healthy tissue, and is differentiated by remote robotic control that allows the surgeon to direct probe positioning from a workstation rather than from inside the MR scan room. Multiple U.S. and international patents cover the system, probes, probe driver, patient board, and AXiiiS stereotactic miniframe.
Monteris generates revenue primarily through direct enterprise sales of capital equipment and per-procedure consumables to hospitals and health systems, supplemented by clinical trial and research support. The company sells through a dedicated North American sales organization (including a VP of North American Sales) into nearly 130 health systems across the U.S. and Canada, with the system used in over 9,000 cumulative clinical cases. Reimbursement has been secured with Medicare, leading commercial insurers, and — as of January 2026 — TRICARE, expanding access to over 9 million U.S. military members and their families. The company has raised approximately $200 million in total capital across multiple equity and debt rounds, with the CEO publicly targeting $100 million in sales, and supports prospective multicenter clinical research including the LAANTERN registry (1,000+ patients) and the REMASTer randomized trial.
Monteris Medical firmographics
Firmographics- Name
- Monteris Medical
- Legal name
- Monteris Medical Corporation
- Website
- https://monteris.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Monteris Medical is a private medical device company that develops the NeuroBlate System, a robotic MR-guided LITT platform for minimally invasive brain surgery. It sells capital equipment and consumables to hospitals and neurosurgeons treating brain tumors, radiation necrosis, and drug-resistant epilepsy across North America.
- Ownership category
- akta.pro rank
Monteris Medical industry classification
Industry- Product category
- Minimally Invasive Neurosurgical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
Keywords
Where Monteris Medical is headquartered
LocationHeadquarters
- HQ city
- Minnetonka
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Monteris Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- NeuroBlate System Capital Equipment Sales: Monteris sells its NeuroBlate System as capital medical equipment to hospitals and health systems. The system includes the main platform, robotic components, and software. Additionally, the company generates revenue from compatible accessories and consumables including laser probes (FullFire, SideFire, NB3) and Mini-Bolt cranial bolts.
- Clinical Trial and Research Support: Monteris supports investigator-initiated research allowing partnership with investigators in LITT early phase research. The company also conducts post-market and randomized multicenter clinical trials including LAANTERN study with over 1,000 patients enrolled.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Monteris Medical product offering
Product offeringCore offering
Monteris Medical develops and sells the NeuroBlate System, the only robotic MR-guided laser ablation platform specifically designed for minimally invasive brain surgery. The system delivers laser interstitial thermal therapy (LITT) for treatment of brain tumors, radiation necrosis, and drug-resistant epilepsy. Revenue is generated through capital equipment sales to hospitals, alongside recurring consumables revenue from laser probes (FullFire, SideFire, NB3) and cranial bolt accessories.
Product overview
Monteris Medical offers a unified medical device platform centered on the NeuroBlate System, the only robotic MR-guided laser ablation technology specifically designed for brain surgery. The system comprises the NeuroBlate capital platform with robotic probe drivers, multiple laser probe options (FullFire and SideFire in various sizes including the NB3 1.6mm), Fusion-S visualization software, and supporting accessories (AtamA patient board, MiniBolt cranial bolts). The NeuroBlate System delivers MRI-guided laser interstitial thermal therapy (LITT) for ablation of brain tumors, radiation necrosis, and drug-resistant epilepsy. Clinical support is provided through prospective multicenter studies including the LAANTERN registry and REMASTer randomized trial, with the system used in nearly 130 health systems across North America.
Differentiator
Problem solved
Functional benefit
Brands
- NeuroBlate System: MR-guided laser ablation platform for minimally invasive neurosurgery, used for brain tumors, radiation necrosis, and drug-resistant epilepsy.
- AtamA System
- Mini-Bolt
Products and services
- NeuroBlate System The only robotic MR-guided laser ablation platform specifically designed for minimally invasive brain surgery, enabling precise destruction of abnormal brain tissue including brain tumors, radiation necrosis, and epileptic foci through laser interstitial thermal therapy (LITT). Sold to hospitals and health systems.
- NeuroBlate NB3 FullFire 1.6mm Laser Probe The smallest commercially available laser probe (1.6mm) for brain lesion ablations, featuring patented cooled laser probe technology for optimized heat propagation and ablation control across various lesion sizes. Consumable used with the NeuroBlate System.
- NeuroBlate FullFire Laser Probe Diffuse-tip laser probe providing versatility for tailoring the approach to each unique lesion. Available in 1.6mm and 3.3mm sizes. Consumable used with the NeuroBlate System.
- NeuroBlate SideFire Laser Probe Directional laser probe offering surgeons versatility to tailor approach for each unique lesion, complementing the FullFire diffuse probe. Consumable used with the NeuroBlate System.
- NeuroBlate Fusion-S Software MRI-guided visualization, control, and efficiency software for brain tissue laser ablation, with 3D volumetric visualization, multi-slice thermal views, a 4–12W power range, unlimited temperature pick points, and built-in safety tools including thermal dose threshold lines and auto-stop options. Software component of the NeuroBlate System.
- AtamA Patient Board System Patient positioning device used in conjunction with the NeuroBlate System to apply focused laser energy while protecting surrounding healthy tissue during MRI-guided brain ablation procedures. Accessory for the NeuroBlate System.
- MiniBolt Cranial Bolt System and Accessories Cranial bolt system designed to work with NeuroBlate robotics to reduce MRI profile and provide access to virtually any brain location for laser probe insertion. Accessory for the NeuroBlate System.
Quantifiable outcome
- Seizure freedom (Engel I) achieved in 64.3% of drug-resistant epilepsy patients at 1 year per LAANTERN study
- +6 more outcomes
Companies that use Monteris Medical
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles2 records
Monteris Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Monteris Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Symphony RoboticscoreStrategic partnership to develop AI-powered micro-robotic platform for brain laser ablation. Combines Symphony's MRI-guided, magnetically actuated micro-robotic arm with Monteris' NeuroBlate LITT system. Partnership aims to enable more precise, micro-invasive surgeries through non-linear trajectories in the brain for treating brain tumors and drug-resistant epilepsy.
Scale indicators8 records
Recent moves6 records
Expansion highlights7 records
Monteris Medical competitors and assessment
Company assessmentBroad incumbents
- Brainlab: Major neurosurgery navigation and planning software vendor with broad cranial and spinal platforms. Competes with Monteris for neurosurgical workflow mindshare and increasingly offers image-guided therapy tools that overlap with NeuroBlate's positioning.
- Accuray (CyberKnife): Manufactures the CyberKnife robotic radiosurgery system, which is a competing modality for many brain tumor and radiation necrosis cases that NeuroBlate also addresses. Often positioned as an alternative rather than complement to LITT.
- Penumbra: Neurovascular device company with a growing footprint in neurosurgery through stroke thrombectomy and more recently brain tumor access tools. Could emerge as a competitor in minimally invasive neurosurgical procedures adjacent to LITT.
- Zimmer Biomet (ROSA): Through its ROSA robotic platform, Zimmer Biomet offers surgical robotics for neurosurgical and orthopedic procedures. While primarily orthopedic-focused, ROSA represents a competing robotic neurosurgery platform for hospitals standardizing their OR robotics.
- Integra LifeSciences: Broad neurosurgery portfolio including cranial closure, dural repair, and image-guided surgery products. Competes for hospital neurosurgery budget and shelf space and offers overlapping cranial access accessories used in LITT workflows.
- Stryker (Navigation): Through its acquired Navigation business (formerly Stryker Leibinger), offers cranial navigation systems used in neurosurgical operating rooms. The VP of Sales at Monteris previously held roles at Stryker Navigation, underscoring the close competitive overlap.
- Elekta (Leksell Gamma Knife): Maker of Leksell Gamma Knife and linear accelerators used for stereotactic radiosurgery of brain tumors and functional disorders including epilepsy. Represents the dominant alternative modality for many indications NeuroBlate targets.
Emerging players
- Renishaw (neuromate): UK-based manufacturer of the neuromate stereotactic robotic system for neurosurgery. Smaller and more niche than Monteris but offers robotic stereotactic placement for DBS and ablation procedures, competing for neurosurgery robotics budgets.
Direct peers
- ClearPoint Neuro: Provides MRI-guided neurosurgical navigation and drug delivery platforms used in conjunction with LITT procedures. ClearPoint's cannulas and navigation system are often used alongside NeuroBlate, making it both a partner and a competitor in the MRI-guided neurosurgery workflow.
- Medtronic (Visualase): Acquired Visualase in 2014, the other commercially available MR-guided laser interstitial thermal therapy system for brain surgery. Visualase is the closest direct competitor to Monteris' NeuroBlate, both targeting brain tumors and epilepsy with MRI-guided laser ablation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Monteris Medical social profiles
Digital presenceMonteris Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Monteris Medical leadership team
Management profileNumber of profiles
Profiles9 records
Monteris Medical funding detail
Funding detailFunding overview
Funding rounds20 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Monteris Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Monteris Medical
What does Monteris Medical do?
Monteris Medical develops and sells the NeuroBlate System, the only robotic MR-guided laser ablation platform specifically designed for minimally invasive brain surgery. The system delivers laser interstitial thermal therapy (LITT) for treatment of brain tumors, radiation necrosis, and drug-resistant epilepsy. Revenue is generated through capital equipment sales to hospitals, alongside recurring consumables revenue from laser probes (FullFire, SideFire, NB3) and cranial bolt accessories.
Is Monteris Medical a public or private company?
Monteris Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Monteris Medical founded?
Monteris Medical was founded in 1999. It employs 101 to 250 people.
Where is Monteris Medical based?
Monteris Medical is headquartered in Minnetonka, United States, in the North America region.
How does Monteris Medical make money?
Two revenue lines are on record. NeuroBlate System Capital Equipment Sales are the primary driver. The others are clinical Trial and Research Support.
Who are Monteris Medical's main competitors?
Broad incumbents on record are Brainlab, Accuray (CyberKnife), Penumbra, Zimmer Biomet (ROSA), Integra LifeSciences, Stryker (Navigation) and Elekta (Leksell Gamma Knife). Renishaw (neuromate) is listed as an emerging player. Direct peers are ClearPoint Neuro and Medtronic (Visualase).
Does Monteris Medical have an API?
No public API is recorded for Monteris Medical.
What industry is Monteris Medical in?
Monteris Medical's product category is Minimally Invasive Neurosurgical Devices. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 339112 and its SIC code is 3841.